Skip to main content
SpringerLink
Log in

Conventional or Gadolinium containing contrast media: the choice between acute renal failure or Nephrogenic Systemic Fibrosis?

  • Perspective
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Perazella MA (2007) Nephrogenic systemic fibrosis, kidney disease, and gadolinium: is there a link? Clin J Am Soc Nephrol 2: 200–202

    Article  CAS  Google Scholar 

  • Galan A, Cowper SE, Bucala R (2006) Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy). Curr Opin Rheumatol 18: 614–617

    Article  PubMed  Google Scholar 

  • Cowper SE (2003) Nephrogenic fibrosing dermopathy: The first six years. Curr Opin Rheumatol 15: 785–790

    Article  PubMed  Google Scholar 

  • Cowper SE, Bucala R (2003) Nephrogenic fibrosing dermopathy: Suspect identified, motive unclear. Am J Dermatopathol 25: 358

    Article  PubMed  Google Scholar 

  • Ting WW, Stone MS, Madison KC, Kurtz K (2003) Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 139: 903–906

    Article  PubMed  Google Scholar 

  • Jimenez SA, Artlett CM, Sandorfi N, Derk C, Latinis K, Sawaya H, Haddad R, Shanahan JC (2004) Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin. Arthritis Rheum 50: 2660–2666

    Article  PubMed  CAS  Google Scholar 

  • Gibson SE, Farver CF, Prayson RA (2006) Multiorgan involvement in nephrogenic fibrosing dermopathy: an autopsy case and review of the literature. Arch Pathol Lab Med 130: 209–212

    PubMed  Google Scholar 

  • Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA (2007) Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 188: 586–592

    Article  PubMed  Google Scholar 

  • Dhaun N, Goddard J, Webb DJ (2006) The endothelin system and antagonism in chronic kidney disease. J Am Soc Nephrol 17: 943–955

    Article  PubMed  CAS  Google Scholar 

  • Cowper SE (2007) Nephrogenic fibrosing dermopathy [NFD/NFS Website]. Volume 2007 Yale University

  • Grobner T (2006) Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21: 1104–1108

    Article  PubMed  CAS  Google Scholar 

  • Marckmann P, Skov L, Rossen L, Dupont A, Damholt MB, Heaf JG, Thomsen HS (2006) Nephrogenic systemic fibrosis: Suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17: 2359–2362

    Article  PubMed  Google Scholar 

  • Boyd AC, Zic JA, Abraham JL (2007) Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 56: 27–30

    Article  PubMed  Google Scholar 

  • High WA, Ayers RA, Chandler J, Zito G, Cowper SE (2007) Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56: 21–26

    Article  PubMed  Google Scholar 

  • Deo A, Fogel M, Cowper SE (2007) Nephrogenic systemic fibrosis: A population study examining the relationship of disease development to gadolinium exposure. Clin J Am Soc Nephrol 2: epub ahead of print

  • Swaminathan S, Ahmed I, McCarthy J, Albright R, Pittelkow M, Caplice N, Griffin MD, Leung N (2006) Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy. Ann Intern Med 145: 234–235

    PubMed  Google Scholar 

  • Yerram P, Saab G, Karuparthi PR, Hayden MR, Khanna R (2007) Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure – role of gadoliniumbased contrast media in causation and the beneficial effect of intravenous sodium thiosulfate. Clin J Am Soc Nephrol 2: epub ahead of print

  • Swan SK, Lambrecht LJ, Townsend R, Davies BE, McCloud S, Parker JR, Bensel K, LaFrance ND (1999) Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment. Invest Radiol 34: 443–448

    Article  PubMed  CAS  Google Scholar 

  • Saitoh T, Hayaska K, Tanaka Y, Kuno T, Nagura Y (2006) Dialyzability of gadodiamide in hemodialysis patients. Radiat Med 24: 445–451

    Article  PubMed  CAS  Google Scholar 

  • Joffe P, Thomsen HS, Meusel M (1998) Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Acta Radiol 5: 491–502

    Article  CAS  Google Scholar 

  • Evans C (1990) Biochemistry of Lanthanides. Plenum Press, New York

    Google Scholar 

  • Lazar G (1973) The reticuloendothelial-blocking effect of rare earth metals in rats. J Reticuloendothel Soc 13: 231–237

    PubMed  CAS  Google Scholar 

  • Runge VM (2001) Safety of magnetic resonance contrast media. Top Magn Reson Imaging 12: 309–314

    Article  PubMed  CAS  Google Scholar 

  • Mann JS (1993) Stability of gadolinium complexes in vitro and in vivo. J Comput Assist Tomogr 17 [Suppl 1]: S19–S23

    PubMed  Google Scholar 

  • White GW, Gibby WA, Tweedle MF (2006) Comparison of Gd (DPTA-BMA) versus Gd (HP-DO3A) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy. Invest Radiol 41: 272–278

    Article  PubMed  Google Scholar 

  • Rees J, Spencer A, Wilson S, Reid A, Harpur E (1997) Time course of stomach mineralization, plasma, and urinary changes after a single intravenous administration of gadolinium(III) chloride in the male rat. Toxicol Pathol 25: 582–589

    PubMed  CAS  Google Scholar 

  • Khurana A, Runge VM, Narayanan M, Greene JFJ, Nickel AE (2007) Nephrogenic systemic fibrosis: A review of 6 cases temporally related to gadodiamide injection (Omniscan). Invest Radiol 42: 139–145

    Article  PubMed  Google Scholar 

  • Chiu H, Wells G, Carag H, Canova E, Firpi RJ (2004) Nephrogenic fibrosing dermopathy: A rare entity in patients awaiting liver transplantation. Liver Transpl 10: 465–466

    Article  PubMed  Google Scholar 

  • Baron PW, Cantos K, Hillebrand DJ, Hu KQ, Ojogho ON, Nehlsen-Cannarella S, Concepcion W (2003) Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis. Am J Dermatopathol 25: 204–209

    Article  PubMed  Google Scholar 

  • Moschella SL, Kay J, Mackool BT, Liu V (2004) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 35-2004. A 68-yearold man with end-stage renal disease and thickening of the skin. N Engl J Med 351: 2219–2227

    Article  PubMed  CAS  Google Scholar 

  • Edsal LC, English JC III, Patterson JW (2004) Calciphylaxis and metastatic calcification associated with nephrogenic fibrosing dermopathy. J Cutan Pathol 31: 247–253

    Article  Google Scholar 

  • Levy EM, Viscoli CM, Horwitz RI (1996) The effect of acute renal failure on mortality. A cohort analysis. Jama 275: 1489–1494

    Article  PubMed  CAS  Google Scholar 

  • McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, Tumlin J (2006) Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 98: 5K–13K

    Article  PubMed  CAS  Google Scholar 

  • Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR Jr (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105: 2259–2264

    Article  PubMed  Google Scholar 

  • McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW (1997) Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103: 368–375

    Article  PubMed  CAS  Google Scholar 

  • Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, Pichard AD, Satler LF, Leon MB (2000) The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36: 1542–1548

    Article  PubMed  CAS  Google Scholar 

  • Dittrich E, Puttinger H, Schillinger M, Lang I, Stefenelli T, Horl WH, Vychytil A (2006) Effect of radio contrast media on residual renal function in peritoneal dialysis patients – a prospective study. Nephrol Dial Transplant 21: 1334–1339

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Division of Nephrology, Innsbruck Medical University, Innsbruck, Austria

    Alexander R. Rosenkranz

Authors
  1. Alexander R. Rosenkranz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Grobner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gert J. Mayer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexander R. Rosenkranz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosenkranz, A., Grobner, T. & Mayer, G. Conventional or Gadolinium containing contrast media: the choice between acute renal failure or Nephrogenic Systemic Fibrosis?. Wien Klin Wochenschr 119, 271–275 (2007). https://doi.org/10.1007/s00508-007-0801-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-007-0801-8

Keywords

Search

Navigation